Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jason Farrar to Antibodies, Viral

This is a "connection" page, showing publications Jason Farrar has written about Antibodies, Viral.

 
Connection Strength
  
 
 
0.721
  
  1. Wei J, Matthews PC, Stoesser N, Maddox T, Lorenzi L, Studley R, Bell JI, Newton JN, Farrar J, Diamond I, Rourke E, Howarth A, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Pouwels KB, Walker AS, Eyre DW. Anti-spike antibody response to natural SARS-CoV-2 infection in the general population. Nat Commun. 2021 10 29; 12(1):6250.
    View in: PubMed
    Score: 0.198
  2. Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoa le N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT, Horby P. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection. J Infect. 2015 Feb; 70(2):187-96.
    View in: PubMed
    Score: 0.121
  3. Tricou V, Vu HT, Quynh NV, Nguyen CV, Tran HT, Farrar J, Wills B, Simmons CP. Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis. 2010 May 28; 10:142.
    View in: PubMed
    Score: 0.090
  4. Wei J, Matthews PC, Stoesser N, Newton JN, Diamond I, Studley R, Taylor N, Bell JI, Farrar J, Kolenchery J, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Walker AS, Pouwels KB, Eyre DW. Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK. Nat Commun. 2023 05 16; 14(1):2799.
    View in: PubMed
    Score: 0.055
  5. Wei J, Matthews PC, Stoesser N, Diamond I, Studley R, Rourke E, Cook D, Bell JI, Newton JN, Farrar J, Howarth A, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Walker AS, Eyre DW, Pouwels KB. SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection. Nat Commun. 2022 06 29; 13(1):3748.
    View in: PubMed
    Score: 0.052
  6. Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta KD, House T, Hay J, Bell JI, Newton JN, Farrar J, Crook D, Cook D, Rourke E, Studley R, Peto TEA, Diamond I, Walker AS. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat Med. 2021 12; 27(12):2127-2135.
    View in: PubMed
    Score: 0.049
  7. Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, Bell JI, Newton JN, Farrar J, Diamond I, Rourke E, Howarth A, Marsden BD, Hoosdally S, Jones EY, Stuart DI, Crook DW, Peto TEA, Pouwels KB, Eyre DW, Walker AS. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol. 2021 09; 6(9):1140-1149.
    View in: PubMed
    Score: 0.049
  8. Horwood PF, Duong V, Laurent D, Mey C, Sothy H, Santy K, Richner B, Heng S, Hem S, Cheval J, Gorman C, Dussart P, de Jong MD, Kerleguer A, Guillard B, Murgue B, Lecuit M, de Lamballerie X, Farrar JJ, Tarantola A, Eloit M, Buchy P. Aetiology of acute meningoencephalitis in Cambodian children, 2010-2013. Emerg Microbes Infect. 2017 May 24; 6(5):e35.
    View in: PubMed
    Score: 0.036
  9. van Doorn HR, Kinh Nv, Tuan HM, Tuan TA, Minh NN, Bryant JE, Hang Vt, Uyen le TT, Thinh le Q, Anh Tt, Lan NP, Trung NV, Taylor W, Merson L, Wertheim HF, Farrar J, Wolbers M, Chau Nv, de Jong MD. Clinical validation of a point-of-care multiplexed in vitro immunoassay using monoclonal antibodies (the MSD influenza test) in four hospitals in Vietnam. J Clin Microbiol. 2012 May; 50(5):1621-5.
    View in: PubMed
    Score: 0.025
  10. Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, Kroeger A, Vazquez S, Ruiz D, Martinez E, Mercado JC, Balmaseda A, Harris E, Dimano E, Leano PS, Yoksan S, Villegas E, Benduzu H, Villalobos I, Farrar J, Simmons CP. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis. 2010 Aug 31; 4(8).
    View in: PubMed
    Score: 0.023
  11. Thai KT, Phuong HL, Thanh Nga TT, Giao PT, Hung le Q, Van Nam N, Binh TQ, Simmons C, Farrar J, Hien TT, van Doorn HR, de Jong MD, de Vries PJ. Clinical, epidemiological and virological features of Dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever. J Infect. 2010 Mar; 60(3):229-37.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.